Literature DB >> 19030989

The polyphenol piceid destabilizes preformed amyloid fibrils and oligomers in vitro: hypothesis on possible molecular mechanisms.

Céline Rivière1, Jean-Claude Delaunay, Françoise Immel, Christophe Cullin, Jean-Pierre Monti.   

Abstract

Alzheimer's disease (AD) is characterized by deposits of amyloid in various tissues. The neuronal cytotoxicity of Abeta peptides is attributed not only to various mechanisms but also to amyloid fibrils and soluble oligomeric intermediates. Consequently, finding molecules to prevent or reverse the oligomerization and fibrillization of Abeta could be of therapeutic value in the treatment of AD. We show that piceid, a polyphenol of the stilbene family, destabilized fibrils and oligomers to give back monomers that are not neurotoxic molecules. The mechanism of this destabilization could be a dynamic interaction between the polyphenol and the Abeta that could open the hydrophobic zipper and shift the reversible equilibrium "random coil<-->beta-sheet" to the disordered structure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19030989     DOI: 10.1007/s11064-008-9883-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  70 in total

1.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

Authors:  D M Walsh; D M Hartley; Y Kusumoto; Y Fezoui; M M Condron; A Lomakin; G B Benedek; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

2.  Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation.

Authors:  E Hughes; R M Burke; A J Doig
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

3.  Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease.

Authors:  Hani Atamna; Kathleen Boyle
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

4.  Nicotine and amyloid formation.

Authors:  H Zeng; Y Zhang; L Peng; H Shao; N K Menon; J Yang; A R Salomon; R P Freidland; M G Zagorski
Journal:  Biol Psychiatry       Date:  2001-02-01       Impact factor: 13.382

5.  Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia.

Authors:  Brian J Tabner; Omar M A El-Agnaf; Stuart Turnbull; Matthew J German; Katerina E Paleologou; Yoshihito Hayashi; Leanne J Cooper; Nigel J Fullwood; David Allsop
Journal:  J Biol Chem       Date:  2005-09-01       Impact factor: 5.157

6.  Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity.

Authors:  Stéphane Bastianetto; Zhi-Xing Yao; Vassilios Papadopoulos; Rémi Quirion
Journal:  Eur J Neurosci       Date:  2006-01       Impact factor: 3.386

7.  First observation of solution structures of bradykinin-penta-O-galloyl-D-glucopyranose complexes as determined by NMR and simulated annealing.

Authors:  Sarah Vergé; Tristan Richard; Serge Moreau; Alain Nurich; Jean-Michel Merillon; Joseph Vercauteren; Jean-Pierre Monti
Journal:  Biochim Biophys Acta       Date:  2002-06-06

8.  Polyphenol/peptide binding and precipitation.

Authors:  Adrian J Charlton; Nicola J Baxter; M Lokman Khan; Arthur J G Moir; Edwin Haslam; Alan P Davies; Michael P Williamson
Journal:  J Agric Food Chem       Date:  2002-03-13       Impact factor: 5.279

9.  Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro.

Authors:  Kenjiro Ono; Kazuhiro Hasegawa; Hironobu Naiki; Masahito Yamada
Journal:  Biochim Biophys Acta       Date:  2004-11-05

Review 10.  Disease modifying therapy for AD?

Authors:  Todd E Golde
Journal:  J Neurochem       Date:  2006-11       Impact factor: 5.372

View more
  8 in total

Review 1.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.

Authors:  Colin L Masters; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

2.  Aromatic small molecules remodel toxic soluble oligomers of amyloid beta through three independent pathways.

Authors:  Ali Reza A Ladiwala; Jonathan S Dordick; Peter M Tessier
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

3.  Polyphenolic glycosides and aglycones utilize opposing pathways to selectively remodel and inactivate toxic oligomers of amyloid β.

Authors:  Ali Reza A Ladiwala; Mauricio Mora-Pale; Jason C Lin; Shyam Sundhar Bale; Zachary S Fishman; Jonathan S Dordick; Peter M Tessier
Journal:  Chembiochem       Date:  2011-06-10       Impact factor: 3.164

4.  Cryptotanshinione inhibits β-amyloid aggregation and protects damage from β-amyloid in SH-SY5Y cells.

Authors:  Zhengrong Mei; Pengke Yan; Bing Situ; Yonggao Mou; Peiqing Liu
Journal:  Neurochem Res       Date:  2011-11-19       Impact factor: 3.996

Review 5.  Polyphenols as therapeutic molecules in Alzheimer's disease through modulating amyloid pathways.

Authors:  Johant Lakey-Beitia; Ruben Berrocal; K S Rao; Armando A Durant
Journal:  Mol Neurobiol       Date:  2014-05-15       Impact factor: 5.590

6.  Water deficit increases stilbene metabolism in Cabernet Sauvignon berries.

Authors:  Laurent G Deluc; Alain Decendit; Yorgos Papastamoulis; Jean-Michel Mérillon; John C Cushman; Grant R Cramer
Journal:  J Agric Food Chem       Date:  2010-12-03       Impact factor: 5.279

7.  Protective Effects of Polydatin Against Dementia-Related Disorders.

Authors:  Kim San Tang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

8.  Destabilization potential of beta sheet breaker peptides on Abeta fibril structure: an insight from molecular dynamics simulation study.

Authors:  Vinod Jani; Uddhavesh Sonavane; Rajendra Joshi
Journal:  RSC Adv       Date:  2021-07-05       Impact factor: 4.036

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.